Barang, Alexander C.
HRN: 24-59-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/27/2024
03/01/2024
IVTT
35mg
Q24
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes